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Abstract
Background: Mosquitoes host and pass on to humans a variety of disease-causing pathogens such as infectious
viruses and other parasitic microorganisms. The emergence and spread of insecticide resistance is threatening the
effectiveness of current control measures for common mosquito vector borne diseases, such as malaria, dengue
and Zika. Therefore, the emerging resistance to the widely used pyrethroid insecticides is an alarming problem for
public health. Herein we demonstrated the use of RNA interference (RNAi) to increase susceptibility of adult
mosquitoes to a widely used pyrethroid insecticide.
Methods: Experiments were performed on a field-collected pyrethroid resistant strain of Ae. aegypti (Rio de Janeiro; RJ).
Larvae from the resistant Ae. aegypti population were soaked with double-stranded RNAs (dsRNAs) that correspond
either to voltage-gate sodium channel (VGSC), P-glycoprotein, or P450 detoxification genes and reared to adulthood.
Adult mortality rates in the presence of various Deltamethrin pyrethroid concentrations were used to assess mosquito
insecticide susceptibility.
Results: We characterized the RJ Ae. aegypti strain with regard to its level of resistance to a pyrethroid insecticide and
found that it was approximately 6 times more resistant to Deltamethrin compared to the laboratory Rockefeller strain.
The RJ strain displayed a higher frequency of Val1016Ile and Phe1534Cys substitutions of the VGSC gene. The resistant
strain also displayed a higher basal expression level of VGSC compared to the Rockefeller strain. When dsRNA-treated
mosquitoes were subjected to a standard pyrethroid contact bioassay, only dsRNA targeting VGSC increased the adult
mortality of the pyrethroid resistant strain. The dsRNA treatment proved effective in increasing adult mosquito
susceptibility over a range of pyrethroid concentrations and these results were associated with dsRNA-specific small
interfering RNAs in treated adults, and the corresponding specific down regulation of VGSC gene expression level.
Finally, we demonstrated that the efficiency of our approach was further improved by ‘tiling’ along the VGSC gene in
order to identify the most potent dsRNA sequences.
Conclusions: These results demonstrate that dsRNA applied to mosquito larvae retains its biological activity into
adulthood. Thus, the RNAi system reported here could be a useful approach to control the widespread insecticide
resistance in mosquitoes and other insect vectors of human diseases.
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Background
Mosquitoes are responsible for a huge detrimental im-
pact on global public health. They are by far the deadli-
est animals to humans on the planet [1]. Approximately
3.3 to 3.6 billion people are at risk of being infected by
dengue or malaria, with around 21,000 dengue related
deaths and 600,000 malaria related deaths annually [2].
Vector control still constitutes the critical element in the
current global strategies for the control of vector-borne
diseases such as malaria, Yellow fever, filariasis, Japanese
encephalitis, West Nile fever, Rift Valley fever, Saint
Louis encephalitis, chikungunya, dengue and Zika [3].
The Zika virus belongs to the family Flaviviridae and is
transmitted to humans by Aedes aegypti mosquitoes
[4]. Zika virus infection in pregnant women has been
associated with various embryonic defects and abortion.
Recently, two independent studies demonstrated that
Zika causes placental damage as well as fetal intrauter-
ine growth restriction, microcephaly and death in mice
[5, 6]. The expanding Aedes aegypti spread and the
emerging Zika virus disease are of worldwide concern.
For controlling the Zika and dengue vector Aedes
(Stegomyia) aegypti (Linnaeus, 1762), several different
approaches have been recently developed, such as the
use of transgenic mosquitoes and Wolbachia-infected
mosquitoes [7]. However, the traditional methods, i.e.
environmental sanitation measures and chemical con-
trol are still the most widely used. For dengue control,
efficient programs against Ae. aegypti were imple-
mented in the late 1940s and early 1950s, resulting in
the elimination of this species in almost all of the
Americas, including Brazil [8]. Indoor residual spraying
(IRS) and pyrethroid impregnated bed-nets (ITN) both
targeting the Anopheles vector, led to unprecedented
success in malaria prevention in Africa, preventing hun-
dreds of millions of malaria cases over the last decade [9].
Although this chemical control has proven effective, it is
fickle. The intensive use of insecticides and the constant
exposure to them is resulting in strong selection pressure
and development of resistance [10]. Indeed, recent moni-
toring of malaria vectors showed that resistance levels are
increasing, 53 countries reported resistance to at least one
insecticide, and 41 countries reported resistance to two or
more insecticide classes [2, 11].
There are four main groups of neurotoxic insecticides
registered for use for public health purposes, but pyre-
throids are considered the most effective and safest in-
secticide class to combat the adult vectors [12, 13]. All
pyrethroids act on the same target protein, the voltage-
gated sodium channel (VGSC). This adulticide keeps
VGSC neuron membranes open, stimulating the nerve
cells to produce repetitive discharges which eventually
cause paralysis and mosquito death [14]. To date, two
main mechanisms are involved in pyrethroid resistance:
enhanced metabolic detoxification and target site in-
sensitivity [15, 16]. Indeed, single amino acid substitu-
tions resulting from mutations in the VGSC gene have
been associated with target site insensitivity to this class
of insecticides. In natural populations of Ae. aegypti the
most common mutations associated with resistance are
the V1016G, F1534C [10, 17–19] and in Anopheles sp. is
the L1014F [20, 21].
Among the new approaches implemented for pest
control, one of the most promising is RNA interference
(RNAi). RNAi is an evolutionarily conserved regulatory
mechanism found in almost all eukaryotic organisms,
which downregulates gene expression in a sequence-
specific manner. RNAi is induced by the presence of
double-stranded RNA (dsRNA) that is then processed by
Dicer into small interfering RNAs (siRNAs). Later, the
siRNAs recruit and guide the RNA-induced silencing
complex (RISC) to the complementary RNA sequence,
which is then cleaved and degraded [22–25]. The re-
cruitment of this mechanism has led to the development
of new methods for insect pest control, manipulation of
insect disease vectors and disease management of bene-
ficial insects [26–33]. Importantly, large-scale field im-
plementation of this technology has proven to be
successful in honey bees [34].
In mosquitoes, dsRNA delivered to larvae, resulted in
increased toxicity of the larvicide temephos [35]. Add-
itionally, dsRNA fed directly to adults achieved a gene
knockdown effect at 48 h post-feeding [36]. However,
these findings were focused on delivering dsRNA and
assessing gene silencing and related-phenotype in the
same mosquito developmental stage. Recent observa-
tions suggest that RNAi triggered in mosquito larvae
could be maintained until adulthood [37, 38]. Neverthe-
less, these studies did not establish molecular evidence
for a RNAi mechanism that persists across developmen-
tal stages in mosquitoes.
Herein we describe a novel RNAi-based approach for
vector control. Through treating Ae. aegypti mosquito
larvae with dsRNA targeting the VGSC gene, we were
able to induce and characterize long-lasting gene silen-
cing, which persisted into the mosquito adult. Moreover,
the treatment successfully restored pyrethroid suscepti-
bility in a field-collected resistant strain of Ae. aegypti.
This study shows that dsRNA delivered during the mos-
quito larval stage can be potentially useful in integrated
vector control programs, by helping to break down the




Ae. aegypti eggs of the Rockefeller strain (Rock), Rio de
Janeiro strain (RJ, Nova Iguaçu, 23°S, 43°W) were
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obtained from the Laboratório de Fisiologia e Controle
de Artrópodes Vetores of the Instituto Oswaldo Cruz
(Rio de Janeiro). Adult mosquitoes were maintained as
described by Rutledge et al. [39], with modifications.
Briefly, mosquitoes were fed on a 10 % sugar solution
and were reared at 26–28 °C, 70–80 % relative humidity
and a 12:12 photoperiod. Adult females were fed with
artificial feeders, using natural pork gut membrane and
defibrinated sheep blood (LaborclinW).
DsRNA synthesis
Total cDNA from Ae. aegypti adults was employed as
the template for synthesis of dsRNA sequences using
specific primers containing T7 promoter sequences.
The dsRNAs were synthetized by in vitro transcription
using Megascript RNAi kit (Ambion) according to the
manufacturer’s instructions. Integrity and purity of
dsRNA were verified by non-denaturing 1 % agarose
gel electrophoresis, and concentration was determined
spectrophotometrically. We produced one dsRNA se-
quence targeting the Ae. aegypti CYP9J26 gene [NCBI:
XM_001649047.2, VectorBase: AAEL014609-RA], one
targeting the CYP9J32 gene [NCBI: XM_001653404.2, Vec-
torBase: AAEL008846-RA], one targeting P-glycoprotein
gene [NCBI: XM_001654442.1, VectorBase: AAEL010379-
RA], and sequences targeting the VGSC gene [NCBI:
KC107440.1, VectorBase: AAEL006019-RD]: the VGSC422
dsRNA and 8 different tiling sequences (Tile 1, Tile 2, Tile
3, Tile 4, Tile 5, Tile 6, Tile 7 and Tile 8). The primer se-
quences, as well as the position of each dsRNA in the
VGSC gene are indicated in Additional file 1. Artificial
dsRNA (Random-dsRNA) sequence, which has no perfect
homology greater than 19 bp with the Ae. aegypti genome,
was generated by “Random DNA Sequence Generator”
(http://www.faculty.ucr.edu/~mmaduro/random.htm). The
Random-dsRNA’s full sequence (357 bp excluding the T7
promoters) is shared in Additional file 2. Additional
dsRNA (Random, VGSC422 and VGSCT6) was purchased
from AgroRNA.
DsRNA soaking assay
For each treatment, 100 third instar larvae were placed
inside a 50 ml plastic cup with 50 μl of autoclaved food
solution (6 g/100 ml – 40 % cat food, 40 % rabbit food,
10 % yeast, 10 % fish flakes) and the desired amount of
indicated dsRNA ranging from 0.05 to 0.5 μg/μl in a
total of 3 ml autoclaved water. The untreated group was
kept in 3 ml autoclaved water as the control group. One
hundred third instar larvae were soaked for 24 h and
after that transferred to a new tray with 1 l of aged
water. Larvae were allowed to develop until they became
adults. All procedures and larval development were per-
formed at 26–28 °C. Adult females were used in the
adulticide bioassays as described below.
Pyrethroid bioassays
Deltamethrin (PESTANALW; Sigma-Aldrich) diluted in
acetone was used in the adulticide bioassays, performed
as previously described [40]. Bottles with acetone only
served as a control. The resistance status of the RJ
population (without dsRNA treatment of larvae) was
measured and compared to the Rock strain using quali-
tative assays (diagnostic dose: 2 μg/ml; diagnostic time:
30 min). The knockdown effect was evaluated after
24 h into the pyrethroid bioassay. Populations with a
mortality rate above 98 % were considered susceptible;
whereas populations with mortality rates below 80 %
were considered resistant. Populations with mortality
rates between 80 and 98 % were considered populations
with modifications in susceptibility [41].
For the quantitative bioassays, female adults (with
dsRNA treatment of larval stage) were exposed for
30 min at different deltamethrin concentrations, ran-
ging from 0 to 2 μg/ml, or at the indicated concen-
tration. Three to four bottles (250 ml) were
impregnated with each insecticide concentration. For
each bottle, 10 to 15 unfed females (5–7 day-old
maximum) were used. Females (live and dead) were
immediately collected following the bioassays. After
flash freezing, samples were stored at -80 °C for ana-
lysis of gene silencing.
Mating assay and F1 generation effect
Third instar larvae were treated with VGSC dsRNA or
left untreated and grown until the pupal stage where the
pupae were separated by sex within each treatment. The
sex separation was performed at the pupal stage in order
to ensure that all the females remain virgin. After their
emergence, the adults were crossed as follows: X1 males
untreated (water) crossed with females untreated
(water); X2 males treated with dsRNA VGSC crossed
with females treated with dsRNA VGSC; X3 males
treated with dsRNA VGSC crossed with females un-
treated (water); X4 males untreated (water) crossed with
females treated with dsRNA VGSC. After mating, the fe-
males within each crossing were blood fed and allowed
to lay their eggs. These eggs (F1 generation) were grown
until the adult stage and then were used for the pyreth-
roid bioassay.
Genotyping assays
Individual mosquitoes from either RJ or Rock strain
were genotyped at position 1016 and 1534 of the gen-
omic DNA using allele-specific PCR (AS-PCR). Follow-
ing DNA extraction, PCR reactions were performed
using GoTaqW Green Mastermix (Promega Corporation),
100 ng genomic DNA, 0.24 μM of the reverse primer
and 0.12 μM of each one of the forward primer with a
final volume of 12.5 μl. The amplification reactions were
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performed according to reference [42]. The sequences of
primers used were described by Linss et al. [10] and are
shown in Additional file 3.
The amplified alleles were analyzed on a 10 % poly-
acrylamide gel. For the mutation Val1016Ile, a 78 bp
band refers to the mutant allele (1016Ile) and a band
with 98 bp represents the wild type allele (1016Val). For
the mutation Phe1534Cys, the 110 bp band is in linkage
with the mutant allele (1534Cys) and the 90 bp band is
linked to the wild type allele (1534Phe).
Reverse transcription and relative mRNA quantification
VGSC expression levels were measured using Real time
PCR following the 2-ΔΔCT method [43]. Total RNA was
extracted using TRIzol reagent (Invitrogen Life Tech-
nologies, Carlsbad, CA, USA), according to the manu-
facturer’s instructions. cDNA synthesis was performed
in a final volume of 20 μl, using ImProm-II Reverse
Transcriptase (Promega Corporation, Madison, WI,
USA). The reaction mixture contained 2 μg of total
RNA, 20 pmol of oligo dT primer (Invitrogen Life
Technologies, Carlsbad, CA, USA), 40 U of RNAsin,
1 mM of dNTP mix, and 1 U of reverse transcriptase.
PCR amplification and analysis were achieved using an
ABI Prism 7500 sequence detector (Applied Biosys-
tems, Foster City, CA, USA). All reactions were per-
formed with SYBR Green PCR Master Mix (Applied
Biosystems) using a 10 μl final volume in each reac-
tion, which contained 1 μl of template cDNA, 2.5 pmol
of each primer and 5 μl of SYBR Green. The cycles
were processed according to the manufacturer’s in-
structions. Each sample was tested in duplicate and all
quantifications were normalized using α-tubulin as the
endogenous control. The primers used for all PCR am-
plifications are described in Additional file 1.
Alternatively, mRNA quantification was determined
using the QuantiGene Plex 2.0 branched DNA assay.
Briefly, total RNA from each sample (400 ng) was ana-
lyzed by using a Bio-Plex 200 system array reader with
Luminex 100 X-MAP technology, and data was ac-
quired and analyzed by using Bio-Plex Data Manager
5.0 software (Bio-Rad Laboratories, Hercules, CA). In-
dividual bead-based probe sets specific to the VGSC
gene and the endogenous control gene S7 were de-
signed by Affymetrix and are available in the company’s
website. Assays were performed as recommended by
the manufacturer. Data are shown as relative light units
specific to mRNA expression, with normalization to
levels of the endogenous control gene.
Small RNA sequencing
Total RNA was extracted from a pool of 5 mosquitoes
treated with Random or VGSC422 dsRNAs, using the
Direct-zol™ RNA MiniPrep (Zymo Research), following
the manufacturer’s instructions. RNA quality was veri-
fied using Agilent Total RNA Nano chip on Bioanaly-
zer 2100 instrument, and the quantification of total
RNA for small RNA library preparation was performed
using Qubit RNA BR Assay fluorimetric method (Invi-
trogen, USA).
One microgram (μg) RNA was used to generate a
small RNA sequencing library using the TruSeq
Small RNA Sample Prep Kit 7A (Illumina, USA), ac-
cording to the manufacturer’s instructions. Briefly, T4
RNA ligase and T4 RNA ligase 2 Deletion mutant
(Epicentre part #LR2D1132K, USA) were used to li-
gate RA5 and RA3 oligonucleotides to the 5′ and 3′
ends of the RNA, respectively. Adapter-ligated RNA
was reverse-transcribed using a RTP primer and the
resulting cDNA was amplified in an 11-cycle PCR
that used RP1 and indexed RP1 primers. PCR prod-
ucts of 140–160 bp were isolated following electro-
phoresis through a 4 % agarose gel (Promega).
Quality of the generated small RNA sequencing li-
brary was confirmed using Agilent High Sensitivity
D1000 Screen Tape on TapeStation 2200 instrument.
Sequencing was performed in a Hiseq 2500 (Illumina,
USA) instrument, in a 100 bp single-end read run
using HiSeq SBS clustering and sequencing kit v3-
HS. Base-calling and generation of raw, de-
multiplexed sequencing data in FASTQ format, was
performed using BaseSpace (Illumina, USA) platform.
Processing and analyses of RNA sequencing data
Mapping
Illumina Truseq small RNA 3′ adapters were trimmed
using cutadapt [44] version 1.2.1. Untrimmed reads were
discarded from the analysis. RNA-seq data were aligned to
a broad institute assembly of Ae. aegypti genome [45] using
STAR, an RNA-seq specific aligner, version 2.4.2a [46];
parameters were set for small RNA’s alignment: _outFilter-
MismatchNoverLmax = 0.05, outFilterMatchNmin =
16,_outFilterScoreMinOverLread = 0, outFilterMatchNmi-
nOverLread = 0, alignIntronMax = 1. Reads that were
uniquely mapped to the VGSC gene were subjected to fur-
ther downstream analysis.
Counting and normalization
The number of reads associated with each position along
the silencing region and along the entire sodium channel
mRNA were counted using coverageBed (bedtools ver-
sion 2.17.0). Raw read counts were normalized to one
million mapped reads per sample (i.e. RPM).
Statistical analysis
Statistical analysis was performed with GraphPad prism
6.0 (GraphPad Software Inc,San Diego, CA). The
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corresponding tests performed are indicated in the le-
gend of each figure.
Results
Characterization of pyrethroid resistance based on
biological assays and molecular analysis of mutations in
the VGSC
In order to check the resistance status of the RJ
population, we performed a pyrethroid qualitative
bioassay and found that the RJ population showed
pyrethroid-induced mortality with a mean of 64 % at
the diagnostic dose and time (2 μg/ml; 30 min),
compared to the susceptible Rock strain, in which
100 % of the mosquitoes were already dead (Fig. 1a).
This classifies the population as resistant to pyre-
throids according to the WHO guidelines [41].
Moreover, we characterized the population at a mo-
lecular level through an AS-PCR which revealed that
for the RJ population both mutations that are associ-
ated with pyrethroid resistance [10], Val1016Ile and
Phe1534Cys, exist within the population (Fig. 1b).
For the mutation Val1016Ile 45 individuals were ana-
lyzed and the resistance genotype Ile/Ile is present in
49 % of the population, reaching an allelic frequency
of f(Ile) = 0.59. With the second mutation evaluated,
Phe1534Cys 40 individuals were analyzed and 60 %
of the population is characterized as having a resist-
ance genotype Cys/Cys (n = 40 individuals) reaching a
mutant allelic frequency of 77 % (f(Ile) = 0.77). The
Rock strain proved to have a dominant homozygous
genotype for both mutations (Additional file 4).
Based on WHO guidelines, the biological assay and
the molecular analysis classifies the RJ field population
as resistant to pyrethroid, whereas the Rock population
is susceptible.
Soaking larvae with specific VGSC dsRNA results in gene
silencing and increased pyrethroid susceptibility
Pyrethroid resistance has been related to both metabolic
and target site resistance mechanisms [18, 47]. There-
fore, with the aim of increasing pyrethroid toxicity, we
screened four different dsRNA molecules, targeting
genes associated with insecticide detoxification or target
site insensitivity, including: a) P-glycoprotein gene (PgP),
which is related to a transmembrane protein of xeno-
biotic efflux [35]; b) ’CYP9J26’ and c) ‘CYP9J32’, both as-
sociated with insecticide detoxification through the
cytochrome P450 pathway [48] and d) VGSC, that codes
the transmembrane protein which harbors the target site
of the pyrethroid adulticides [49]. After the dsRNA treat-
ment followed by the pyrethroid bioassay, we found that
the VGSC422 dsRNA treatment increased the mortality
of the RJ strain by about 50 % compared to untreated
mosquitoes (Fig. 2a). The other treatments did not have
any significant effect on mosquito sensitivity to the pyr-
ethroid although dsRNAs corresponding to Pgp and
CYP9J26 triggered gene silencing in the adult stage
(Additional file 5). As the VGSC422 dsRNA is homolo-
gous to the VGSC gene, we checked the VGSC mRNA
expression level in both resistant and susceptible popula-
tions in all developmental stages. We found that the RJ
population has an increased expression of this gene in
the adult stage, compared to the Rock population
(Fig. 2b). Due to the high dose of dsRNA used to treat
the larvae (0.5 μg/μl), we repeated the soaking experi-
ment with decreased dsRNA amounts. This was done to
check if the same phenotype of increased pyrethroid-
Fig. 1 Characterization of pyrethroid resistance of two Ae. aegypti strains. a Five day-old Ae. aegypti female mosquitoes of the insecticide-susceptible
‘Rockefeller’ strain (Rock) and of the insecticide-resistant ‘Rio de Janeiro’ strain (RJ) were exposed to deltamethrin for up to 24 h and the percentage of
mortality is shown. Data represent mean values of three experiments performed in triplicate ± standard deviation (SD). b Allele specific PCRs for
genotyping kdr mutations were performed on adult Ae. aegypti mosquitoes from the RJ strain. Upper and lower panels represent reactions for the
1016 and 1534 mutation sites, respectively. In the upper panel, amplicons of approximately 80 and 100 bp correspond to alleles 1016 Val+ and 1016
Ile-, respectively. In the lower panel, amplicons of 90 and 110 bp correspond to alleles 1534 Phe+ and 1534 Cys-, respectively. Mosquitoes of the
Rockefeller strain were used as positive homozygous dominant control for both mutation sites. C-: no template negative control
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Fig. 2 Silencing of the Ae. aegypti (RJ strain) VGSC results in increased susceptibility to a pyrethroid insecticide. a Mortality percentage in Ae.
aegypti adults from RJ strain (after dsRNA treatment in larval stage) after 30 min of exposure to deltamethrin. Third-instar larvae were soaked in
water (untreated) or in dsRNA corresponding to the VGSC (VGSC422 dsRNA), P-glycoprotein (PgP dsRNA) and P450 enzymes (CYP9J26, CYP9J32).
Data are shown as the mean ± standard deviation of four replicates. Statistics: One-way Anova, followed by Tukey’s multiple comparisons test. b Compara-
tive VGSC gene expression analysis between different developmental stages of Rock and RJ strains. Data are shown as the mean ± SD of 6 replicates. Statis-
tics: Multiple t-test. c Ae. aegypti RJ strain larvae were soaked as described in a, but using three different concentrations of VGSC422, as indicated. Statistics:
One-way Anova followed by Tukey’s multiple comparison test. d VGSC gene expression level was determined by quantitative RT-PCR (qRT-PCR) and per-
formed on untreated or dsRNA-VGSC422 treated (0.5 μg/μL) Ae. aegypti RJ 4th instar larvae. Data are shown as the mean ± SD of 6 experiments performed
in triplicate. Statistics: t-test. e VGSC gene expression level was determined by qRT-PCR and performed on untreated or dsRNA-VGSC422 treated (0.5 μg/μl)
Ae. aegypti RJ adults. Data are shown as the mean ± SD of 8 experiments performed in triplicate. Statistics: t-test. *P< 0.01, ***P< 0.0001; ****P< 0.00001
Fig. 3 Soaking Ae. aegypti larvae with dsRNA-VGSC422 increases adult susceptibility to different concentrations of Deltamethrin. a Mortality percentage in
5 day-old Ae. aegypti adults from RJ strain (after dsRNA treatment in 3rd-instar larval stage - 0.5 μg/μl) at different Deltamethrin pyrethroid concentrations,
after 30 min exposure. Data are shown as the mean ± standard deviation of four replicates, and 3 independent experiments were performed. Statistics:
Two-way Anova followed by Bonferroni multiple comparison test. b Five day-old adult females (three replicates with 5 mosquitoes each) previously
soaked with VGSC422 dsRNA, Random dsRNA or only water (untreated) were analyzed for VGSC mRNA expression levels using the Quantigene method.
Final dsRNA soaking concentration: 0.5 μg/μl. Statistics: One-way Anova followed by Tukey’s multiple comparisons test. *P< 0.01, ***P< 0.0001. W: water
(untreated); R: dsRNA random-treated; S: dsRNA VGSC422-treated
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driven mortality would be consistent at lower dsRNA
concentrations (0.1 and 0.05 μg/μl), but no statistically
significant phenotypic effect was observed (Fig. 2c). As
only 0.5 μg/μl VGSC422 dsRNA showed a phenotype,
we assayed its target gene expression in dsRNA-treated
larvae and adults. We found gene silencing of the
VGSC not only in the treated larvae, but also in adults
(Fig. 2d and e).
To further check efficacy and specificity of the
VGSC422 dsRNA, we then performed a bioassay at
different pyrethroid concentrations. VGSC422 dsRNA
showed increased mortality of 15–35 % in the adults,
compared with both untreated (water) and random
dsRNA-treated mosquitoes (dsRNA with no homology
to the mosquito genome). This difference in mortality
rate is statistically significant at 0.5, 1.0 and 2.0 μg/ml of
deltamethrin-impregnated bottles (Fig. 3a). Again, this
consistent biological effect of increased mortality was
linked to VGSC gene silencing assayed in adult mosqui-
toes and demonstrated by the Quantigene analysis;
VGSC422 dsRNA applied to the larvae resulted in spe-
cific down regulation of the VGSC gene transcript in
adult mosquitoes compared to a random dsRNA se-
quence, proving a specific action of the VGSC422 dsRNA
molecule (Fig. 3b).
Adult mosquitoes treated with VGSC422-dsRNA during the
larval stage carry a siRNA population that corresponds
only to the dsRNA target sequence
In order to identify the presence of VGSC-specific siR-
NAs in adult mosquitoes previously soaked in VGSC422
dsRNA, we prepared and sequenced small-RNA libraries
from a pool of individuals treated by VGSC422-dsRNA
or random-dsRNA. An average of 18,059,680 single-end
100-bp reads were generated per sample, and after per-
forming the quality filter, the small-RNA sequence reads
were aligned to the Ae. aegypti genome. The analysis of
small-libraries constructed from VGSC422 dsRNA-
treated mosquitoes revealed up to a 50.6-fold increase of
small-RNA reads matching the 3′-position of the posi-
tive- and negative-sense RNA strands inside the VGSC
full mRNA region compared with the Random dsRNA-
treated mosquitoes, which corresponds to the 422 bp
VGSC422 dsRNA homologous site (Fig. 4a). Importantly,
no siRNAs were found outside of the dsRNA-
homologous region. The non-appearance of secondary
siRNAs indicates that transitive RNAi does not occur in
mosquitoes. This observation is consistent with the ab-
sence of RNA-dependent RNA polymerases in mosqui-
toes [50, 51]. We also analyzed the size distribution of
small RNAs inside the dsRNA-homologous region. As
depicted in Fig. 4b, these small RNAs comprised an
enriched population of 22 nucleotide length perfectly
matching the dsRNA.
Targeting different sequences (‘tiling’) along the sodium
channel gene generated a refined dsRNA with a greater
pyrethroid efficacy
After proving that the VGSC422 dsRNA treatment to lar-
vae results in greater sensitivity to the pyrethroid adulti-
cide through specific gene silencing, we directed our
efforts to try to detect a dsRNA sequence that would re-
sult in an improved mortality phenotype. This would
manifest as either increased mortality at the concentra-
tion previously used, or by reduction of the dsRNA con-
centration required to achieve a similar effect. To do so,
Fig. 4 VGSC small RNAs persist until the adult stage of Ae. aegypti
treated by dsRNA-VGSC during larval stage. a Small RNA libraries were
constructed from 5 day-old adult mosquitoes previously soaked in
VGSC422 dsRNA or Random dsRNA (0.5 μg/μl) and sequenced using
Hiseq 2500. Data are presented as the number of reads normalized to
one million mapped reads per sample (RPM). Forward strand (sense)
reads are positive RPM values (depicted in blue); reverse strand (anti-
sense) reads are in negative RPM values (depicted in red). Positions for
which RPM values are > = 10 RPM were considered expressed. b Size
distribution of small RNAs matching the VGSC422 transcript (Accession
no. KC107440.1). nt: nucleotides
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we produced eight different but overlapping dsRNAs
corresponding to the VGSC gene, named ‘Tile 1’
through ‘Tile 8’. The dsRNA tiles covered approximately
half of the entire VGSC gene, and six of them are hom-
ologous to all the six transcript variants of VGSC anno-
tated in this work and others (Fig. 5a, Additional file 6).
Each tile was then used for the soaking procedure at
a final concentration of 0.17 μg/μl, three times lower
than the standard assay, and the females that emerged
were subjected to the pyrethroid bioassay. Each tile
sequence had a different effect on total mortality
(Additional file 7). Four tiles out of eight that induced
higher mortality rates in the initial screen were se-
lected and compared to mosquitoes treated with Random
dsRNA (Fig. 5b). From these four different sequences, the
‘Tile 6’ (VGSCT6) proved to be the most potent dsRNA
due to the increased mortality rate and the concentration
used compared with the random control (Fig. 5c) and the
VGSC422 dsRNA (Fig. 2c).
As a clear biological effect resulting from the 3-fold
lower concentration of dsRNA treatment was identified
in T6, we showed that VGSC gene silencing was being
induced. qRT-PCR analysis revealed a statistically sig-
nificant 2.5 fold down regulation of the VGSC gene in
adult mosquitoes treated with VGSCT6 dsRNA com-
pared to Random dsRNA treated mosquitoes (Fig. 5d).
With a refined RNAi trigger, we further investigated
the VGSCT6 dsRNA effect at different adult ages with
regards to pyrethroid sensitivity. Following larval
VGSCT6 dsRNA application, significant and increasing
Fig. 5 RNAi-effect optimization by refining the dsRNA constructs for the VGSC gene. a Schematic representation of 6 transcript variants of VGSC
gene and the 8 overlapping dsRNA sequences used to silence the gene (Tile 1 to Tile 8). Deletion sites in variant RB and RD of variant
AAEL006019 are indicated by a dotted line, as well as the position of mutation Val1016Ile and Phe1534Cys sites. b Mortality percentage of 5 day-
old Ae. aegypti RJ adult females after 30 min exposure to deltamethrin. The adult females were treated at the 3rd larval stage by different dsRNA-
VGSC tiles. Data show the mean ± standard deviation of three replicates from 3 independent experiments performed. Statistics: One-way Anova
followed by Tukey’s multiple comparisons test. c Mortality percentage of 5 day-old Ae. aegypti RJ adult females after 30 min exposure to
deltamethrin. The adult females were treated at the 3rd larval stage by three different concentrations of Random or VGSCT6 dsRNAs. Data are
shown as the mean ± standard deviation of three replicates (2 independent experiments were performed). Statistics: One-way Anova followed by
Tukey’s multiple comparisons test. d VGSC gene expression level was determined by qRT-PCR and performed on dsRNA-Random or dsRNA-
VGSC422 treated and pyrethroid-affected Ae. aegypti RJ adults. Statistics: t-test *P < 0.05, ****P < 0.00001
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pyrethroid susceptibility was detected in 7, 15 and
30 day-old adults. This cross-developmental RNAi ef-
fect was supported by stable VGSC gene knockdown
(Fig. 6). Interestingly, in the absence of pyrethroid, the
VGSCT6 dsRNA uptake did not affect vitality and be-
havior of treated larvae and adults from both Rock and
RJ strains (Additional file 8). Hence, we conclude that
the phenotypic impact of the VGSCT6 dsRNA is spe-
cific and sequence dependent.
Discussion
The emergence and geographical expansion of pyrethroid
resistant mosquito populations is a great concern to
vector-borne disease control measures. In the present
study we report on a gene silencing approach that restores
pyrethroid susceptibility of resistant Ae. aegypti mosqui-
toes. Specific dsRNA application to larvae downregulated
the corresponding sodium channel gene in both larval and
adult stages. This sustainable larva-to-adult silencing was
sufficient to significantly reduce pyrethroid insensitivity
of adults, demonstrating that reversal of insecticide
resistance is a promising approach for pest control.
Resistance to a pyrethroid insecticide could evolve
through various mechanisms including reduced uptake
(behavioral resistance), enhanced metabolic detoxifica-
tion or via gene modification that affects the insecticide’s
affinity to- or activity on its target site [12, 52]. Indeed,
genotyping a wild resistant strain (RJ) revealed two mu-
tations in the VGSC gene that have been associated with
increased resistance to pyrethroids (Fig. 1b) [10, 18]. Al-
though our RNAi screen also included detoxification
components, P450 and PgP, a significant phenotypic ef-
fect was observed only with dsRNA that targets the
VGSC. This does not exclude the involvement of meta-
bolic detoxification in our wild pyrethroid resistant
strain. However, it further supports that the presence of
mutated VGSC is involved in pyrethroid resistance in
our field population.
A few factors including genetic makeup (occurrence of
wild type/mutated VGSC) and insecticide concentration
might interpret our observations regarding pyrethroid
Fig. 6 Soaking Ae. aegypti (RJ strain) larvae with dsRNA-VGSCT6 increases pyrethroid (deltamethrin) susceptibility in adult mosquitoes of different
ages. a Mortality percentage of 7, 15 and 30 day-old adult Ae. aegypti females from the RJ strain after 30 min exposure to deltamethrin
pyrethroid (5 μg/ml). Adults were soaked in 0.5 μg/μl dsRNA in their previous 3rd instar larvae stage. Data represent the mean ± standard
deviation of four treatment replicates, and 3 independent experiments were performed. Statistics: One-way Anova followed by Tukey’s
multiple comparison test. b Adult females (three biological replicates with 5 mosquitoes each) previously soaked (0.5 μg/μl) with VGSCT6
dsRNA, Random dsRNA or only water (untreated) were analyzed by qRT-PCR for VGSC mRNA expression levels. Statistics: One-way Anova
followed by Tukey’s multiple comparisons test. *P < 0.05; **P < 0.01; ***P < 0.0005
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resistance modulation. Mosquitoes expressing only wild
type (WT) VGSC, or co-expressing WT and mutated
VGSCs are susceptible when exposed to standard
pyrethroid concentrations, indicating that the mutated
allele has a recessive effect (reviewed in [42]). Consist-
ently, in the absence of WT channels (i.e. mutated
VGSC are exclusively expressed), resistance to pyre-
throids is detected [18, 53]. This raises the question:
how could RNAi targeting the modified VGSC restore
pyrethroid susceptibility of resistant mosquitoes? We
propose a model in which gene silencing shifts the
VGSC: pyrethroid ratio. The consequence of this ratio
alteration is higher local insecticide concentration per
target site that eventually affects modified channel
function. In this scenario the reduced activity or affinity
of the pyrethroid to the modified VGSC is compensated
by higher insecticide availability, leading to increased
binding, which in turn leads to increased toxicity
(Fig. 7). Further supporting this mode of action,
pyrethroid-induced mortality of resistant RJ mosquitoes
is elevated in a dose-dependent manner (Fig. 3a).
It has been shown that enhanced detoxification ac-
tivity is associated with increased expression of related
metabolic components including the P450 enzymes
[48, 54]. Interestingly, we detected enhanced VGSC ex-
pression in the resistant RJ strain compared to the sen-
sitive Rock strain. Although such target expression
variation might be irrelevant to pyrethroid susceptibil-
ity, it is tempting to propose a potential effect. At low
pyrethroid concentrations, overexpression of the wild
type VGSC might shift the toxin: target ratio, leaving
enough pyrethroid-free channels to stabilize the so-
dium concentration within axonic cells. Alternatively,
overexpression of VGSC could potentially compensate
fitness costs derived from newly evolved structural
modifications; hence, preserving housekeeping proper-
ties while acquiring new traits. Lastly, a cooperative
interaction between highly expressed toxin chelating
alleles and wild type functional alleles would be im-
portant when novel target gene modifications evolve.
Nevertheless, in all scenarios, knockdown of VGSC is
predicted to compromise pyrethroid insensitivity, as
demonstrated by the RNAi experiments in this study.
The aim of this study was to provide a feasible RNAi
solution that can be applied on wild pyrethroid resistant
mosquito populations in the near future. To achieve this,
high dsRNA efficacy at economic quantities is required.
It is recognized that the sodium channel transcript vari-
ability governs its functional diversity including the
emergence of insecticide resistance [55, 56]. Therefore,
to maximize the RNAi effect we tiled a number of
overlapping dsRNA constructs that together target
about half of the VGSC transcript variants annotated
in this work (Fig. 5a). Despite having only 45 % of the
gene covered, following the I-score prediction of
siRNA regions we were able to cover 15 out of 22
siRNA regions pointed out using the I-Score Designer
software (Additional file 9). This strategy provided a
Fig. 7 A proposed RNAi mode of action that impairs pyrethroid resistance. a Susceptible mosquitoes do not carry mutations that affect
pyrethroid activity on the target VGSC (wild type VGSC in orange). The pyrethroid molecules bind to the VGSC and promote a constantly open
state of the VGSC. This results in an increased influx of Na+ ions into the cell, causing repetitive impulses, exhaustion and eventually death. b
Resistant mosquitoes carry mutated modified VGSC (mVGSC in green) with reduced interaction with pyrethroids (red colored “T”). Therefore,
the toxic consequence of the insecticide is nullified when resistant mosquitoes are exposed to the pyrethroid concentration that effects the
susceptible population. c RNAi decreases the mVGSC density and therefore the insecticide:target ratio is shifted when mosquitoes are exposed
to pyrethroid concentrations that have no effect on resistant populations. This ratio alteration represents an increased pyrethroid molecule
number per target. The elevated insecticide concentration makes up for its impaired interaction with the mVGSC target, leading to binding
and the associated harmful effect (red dotted “T”)
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refined dsRNA trigger (tile-6) that increased mortality
with a three-fold decrease in dsRNA amounts com-
pared to the primary VGSC dsRNA construct. Since
tile-6 is not homologous to a unique VGSC sequence
and not predicted to be enriched with high numbers of
active siRNAs (Additional file 9), its relatively high po-
tency is not well understood. We postulate that local
secondary structure of target transcripts plays a role in
dsRNA-derived siRNAs’ efficiency. It is acknowledged
that in field applications dsRNA has to be packaged to
preserve its stability, quantity and delivery. Further ad-
dressing such requirements, similar increased suscepti-
bility to the adulticide effect occurred when dsRNA
was complexed by a polyamine reagent (see Additional
file 10), indicating that naked dsRNA is not crucial for
efficient dsRNA delivery to Ae. aegypti larvae.
RNAi has been applied to modulate mosquito gene ex-
pression in vivo mostly in the adult stage. A few studies
reported on environmental dsRNA uptake (soaking or
ingestion) and systemic RNAi effect in the larval stage
[35, 57]. Lately, Whyard et al. showed that treating lar-
vae with dsRNA corresponding to testis-specific genes
resulted in male sterility phenotype in adults [37]. How-
ever, it has not been established molecularly whether
RNAi that is induced in the larval stage can persist until
adulthood. Our findings demonstrate an active pro-
longed cross-developmental stage, gene silencing that is
effective for at least 35 days post-dsRNA introduction.
The detection of VGSC-specific siRNAs (Fig. 4) coupled
with VGSC silencing in adults (treated with dsRNA-
VGSC as larvae) (Fig. 2e and 3b) is evidence that a suffi-
cient amount of dsRNA was taken up by the larva and
that active RNAi was sustained into adulthood. Interest-
ingly, dsRNA-mediated VGSC knockdown had no ap-
parent deleterious effect on treated larvae and adults in
the absence of the pyrethroid insecticide. This implies
that the VGSC gene is not a suitable RNAi target to
induce mortality in Ae. aegypti possibly due to insuffi-
cient knockdown levels.
In Caenorhabditis elegans, the dsRNA-triggered gene
silencing is amplified by RNA-dependent RNA polymer-
ases as evidenced by secondary siRNAs, and a mobile
RNAi signal could systemically spread to the germ line,
resulting in transgenerational gene silencing [58]. Our
data indicated that despite the potency of the dsRNA
treatment, no secondary amplification of the silencing
signal occurred (Fig. 4). Moreover, our crossing experi-
ments showed that dsRNA-mediated gene silencing is
not passed on to the subsequent generation in Ae.
aegypti (Fig. 8). This could be explained by the degrad-
ation over time of the dsRNA trigger due to the absence
of RNA-dependent RNA polymerase activity in insects
including mosquitoes [50, 51]. It is also consistent with
the dose-dependent persistence over time of dsRNA pre-
viously reported in adult mosquitoes [36].
Conclusions
In conclusion, this work has demonstrated a novel strat-
egy for the control of pyrethroid insecticide-resistant,
disease vectoring mosquitoes. We applied dsRNA to Ae.
aegypti larvae and showed long-lasting gene silencing
that affects adults. The RNAi system was directed to im-
pair resistance to pyrethroids by knocking down the
well-established pyrethroid target, the voltage-gated so-
dium channel. Solving the pyrethroid resistance problem
is of great importance as pyrethroids are the only class
of insecticide approved to treat bed-nets [52]. Moreover,
the approach reported in this study has the potential to
reduce the environmental use of chemicals with broad-
spectrum insecticidal activity such as pyrethroids. It is
proposed that the dsRNA-triggered long term RNAi
could be applied into various complementary strategies
to control mosquitoes at different developmental stages.
Fig. 8 Effect of dsRNA-VGSC422 treatment in F0 on untreated F1 generation. Five day-old males and females previously soaked with dsRNA-
VGSC422 or only water (F0; Parental Generation) were mated as represented in the scheme (left). The F1 generation resulting from indicated mat-
ing was subjected to a bioassay with 0.5 μg/ml of deltamethrin and the mortality is shown (right graph)
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Finally, it should be noted that based on the procedure
reported herein, we are working on additional avenues
to achieve disease vector control.
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Additional file 1: Table showing the list of primers used in Real-time
PCR (qPCR) and in dsRNA production. (PDF 197 kb)
Additional file 2: Artificial random dsRNA sequence with no perfect
homology greater than 19 bp with the Ae. aegypti genome (taxid: 7159).
(PDF 34 kb)
Additional file 3: Table showing the list of primers used to amplify
sodium channel gene mutations in Ae. aegypti. (PDF 162 kb)
Additional file 4: Table showing the frequency of the 1016 and 1534
mutations in the sodium channel gene of the Rio de Janeiro strain of A.
aegypti. (PDF 86 kb)
Additional file 5: Soaking Ae. aegypti larvae (RJ strain) with specific
dsRNA results in P-glycoprotein and CYP9J26 gene silencing during
the larval and/or adult stages. (A-C) Larvae were soaked in water
(untreated) or in dsRNA corresponding to the (A) P-glycoprotein
(PgP) and P450 enzymes (B) CYP9J26 and (C) CYP9J32. Gene
expression levels were determined by qRT-PCR and performed on
untreated or dsRNA-treated (0.5 μg/μl) Ae. aegypti RJ larvae. Data are
shown as the mean ± standard deviation of four biological replicates.
Statistics: One-way Anova, followed by Tukey’s multiple comparison
test. (D-F) Larvae were soaked as described above, and grown to
the adult stage. Individual females were then analyzed for gene
expression as described above. Data are shown as the mean ± SD of
7 females, and the experiment was performed 3 times. Statistics:
Multiple t-test. *P < 0.01. (TIFF 141 kb)
Additional file 6: Table showing the list of all the transcript variants of
VGSC available in the literature. (PDF 168 kb)
Additional file 7: Screening for dsRNA sequence targeting VGSC gene.
Mortality percentage of Ae. aegypti RJ adult females after 30 min
exposure to pyrethroid deltamethrin. The adult females were treated at
the 3rd larval stage by different dsRNA-VGSC tiles (0.17 μg/ul). The graph
shows the mean ± standard deviation of three replicates. Statistics: One-way
Anova, followed by Tukey’s multiple comparison test.* P < 0.01. (TIF 144 kb)
Additional file 8: DsRNA-VGSCT6 application at the larval stage does
not affect vitality and behavior of treated mosquitoes. (A-B)
Percentage of immature mortality (larvae and/or pupae) after dsRNA
treatment (dsRNA-Random or dsRNA-VGSCT6) in the Rockefeller strain
(A) and Rio de Janeiro strain (B). Data are shown as the mean ±
standard deviation of three treatment replicates from two independ-
ent experiments. (C-D) Sex ratio in the Rockefeller (C) and Rio de
Janeiro (D) strains after dsRNA treatment with dsRNA-Random or
dsRNA-VGSCT6. Data are shown as the mean ± standard deviation of
three treatment replicates of two independent experiments. (E-F) Per-
centage of blood fed females in the Rockefeller (E) and Rio de
Janeiro (F) strains after dsRNA treatment (dsRNA-Random or dsRNA-
VGSCT6) in the larval stage. Data are shown as the mean ± standard
deviation of three treatment replicates of two independent experi-
ments. (G-H) Number of eggs per female in the Rockefeller (G) and
Rio de Janeiro (H) strains after dsRNA treatment (dsRNA-Random or
dsRNA-VGSCT6) in the larval stage. Data are shown as the mean ±
standard deviation of three treatment replicates of two independent experi-
ments. (I-J) Hatching rate in the Rockefeller (I) and Rio de Janeiro (J) strains
after treatment with dsRNA-Random or dsRNA-VGSCT6 in the larval stage. Data
are shown as the mean ± standard deviation of three treatment replicates of
two independent experiments. (TIFF 297 kb)
Additional file 9: Table showing the list and hotspot sequences for
siRNA in VGSC gene, using the I-Score Designer software. (PDF 218 kb)
Additional file 10: Alternative dsRNA delivery using solid food.
Groups of 100 3th instar-larvae from Ae. aegypti RJ strain were fed
with three plugs of 300 μl each containing 300 μg of VGSC422 dsRNA
complexed with PEI and dissolved in 2 % of pre-melted
agarose and food solution. Then, larvae were reared until adult stage
and exposed to 0.5 μg/ml of deltamethrin, as described in A. The
percentage of mortality after 30 min is shown. Statistics: Two-way
Anova, followed by Sidak’s multiple comparison test. *P < 0.05.
(TIFF 241 kb)
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